Cerenome, Inc. has secured up to $20 million in a financing facility with 3i Fund to support the commercial scale-up of its CNSide platform. The initial tranche of funding was received at closing with future tranches tied to milestones.
Amount Raised
$20 Million
Round Type
Debt Financing
HoustonManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalHealth DiagnosticsInvestors
Description
Cerenome, Inc. announced a senior secured financing agreement with 3i Fund for up to $20 million with royalty-based repayments. The initial funding was provided at closing, with future tranches linked to achieving certain milestones. This financing will aid in the scale-up of the Company’s CNSide cerebrospinal fluid assay platform
Quick answer
Cerenome, Inc. raised $20 Million in a Debt Financing round, dated September 10, 2026. Investors: 3i, LP. Cerenome, Inc. is based in Houston, Texas, United States.
- How much did Cerenome, Inc. raise?
- Cerenome, Inc. raised $20 Million in a Debt Financing round on September 10, 2026.
- Who invested in Cerenome, Inc?
- 3i, LP is named as investors in this round.
- What does Cerenome, Inc. do?
- Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the potential to enhance clinical outcomes for..
- Where is Cerenome, Inc. based and how big is it?
- Cerenome, Inc. is based in Houston, Texas, United States. Fundz records about 24 employees.
- Who are the decision-makers at Cerenome, Inc?
- Fundz holds 3 contacts at Cerenome, Inc., including the Vice President. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Cerenome, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Tarsus Pharmaceuticals raised $125M (Post-IPO Equity) on August 6, 2026.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Trior raised $25M (Series C) on October 23, 2026.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Float Bio raised $140K (Pre-Seed) on October 15, 2026.
Who to call at Cerenome, Inc., and when
A new round usually means Cerenome, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cerenome, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cerenome, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cerenome, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cerenome, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cerenome, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.